•HRES 286 IH 
bat the global HIV/AIDS pandemic by accelerating and 
coordinating efforts to develop an HIV vaccine; 
Whereas at the meeting in Sea Island, Georgia, under the 
President’s leadership, the Group of Eight endorsed the 
establishment of the Global HIV Vaccine Enterprise; 
Whereas the United States has an HIV vaccine research and 
development center at the National Institutes of Health, 
and the President announced funding for the establish-
ment of a second HIV vaccine research and development 
center in the United States that will become a key com-
pound of the Global HIV Vaccine Enterprise; 
Whereas the Global HIV Vaccine Enterprise has developed 
and published a shared scientific strategy that addresses 
the major obstacles to the development of an HIV vac-
cine, summarizes current scientific priorities, and de-
scribes an initial strategic approach to addressing these 
priorities; and 
Whereas an HIV vaccine has the potential to prevent new 
HIV and AIDS cases, which would save millions of lives 
and dramatically reduce the negative economic con-
sequences of HIV and AIDS: Now, therefore, be it 
Resolved, 
SECTION 1. SENSE OF THE HOUSE OF REPRESENTATIVES 
ON THE DEVELOPMENT OF AN HIV VACCINE. 
It is the sense of the House of Representatives that— 
(1) the President should seek to build on the 
initiative of the members of the Group of Eight 
(Canada, France, Germany, Italy, Japan, Russia, 
the United Kingdom, and the United States) to de-
•HRES 286 IH 
velop a vaccine to curtail the spread of the human 
immunodeficiency virus (hereinafter referred to as 
‘‘HIV’’) and should mobilize necessary economic and 
scientific support for the Global HIV Vaccine Enter-
prise, an alliance of the world’s leading scientists 
and independent organizations committed to accel-
erating the development of a preventive HIV vaccine 
by enhancing coordination, information sharing, and 
collaboration globally; 
(2) the President should continue to urge the 
members of the Group of Eight and other countries 
to garner support from their own economic, sci-
entific, and philanthropic communities for the devel-
opment of an HIV vaccine; 
(3) the members of the Group of Eight should 
follow-up the June 2004 meeting in Sea Island, 
Georgia with official and private meetings, con-
ferences, and other events to further explore and im-
plement initiatives concerning the Global HIV Vac-
cine Enterprise; 
(4) the members of the Group of Eight should 
leverage financial contributions from the inter-
national philanthropic community to provide fund-
ing, including funding to the private sector, to pro-
mote the development of an HIV vaccine;
•HRES 286 IH 
(5) the members of the Group of Eight should 
include the scientific and political leadership of those 
countries most affected by the pandemic of HIV and 
the acquired immune deficiency syndrome (herein-
after referred to as ‘‘AIDS’’); and 
(6) the members of the Group of Eight should 
develop a specific plan for furthering efforts towards 
this goal prior to the meeting of the Group of Eight 
planned for June 2005 in the United Kingdom. 
SEC. 2. THE GLOBAL HIV VACCINE ENTERPRISE. 
The House of Representatives urges the President to 
continue the efforts of the United States to generate glob-
al support for the Global HIV Vaccine Enterprise by car-
rying out an initiative that— 
(1) is in coordination and partnership with the 
members of the Group of Eight, the private sector, 
and other countries, especially those countries most 
affected by the HIV/AIDS pandemic; 
(2) encourages the members of the Group of 
Eight to act swiftly to mobilize money and resources 
to support the Global HIV Vaccine Enterprise; 
(3) includes a strategic plan to prioritize the 
scientific and other challenges to the development of 
an HIV vaccine, as set out in the Scientific Strategic 
Plan developed by the Global HIV Vaccine Enter-